Mocroft A - Search Results

1

Mortality and admission to intensive care units after febrile neutropenia in patients with cancer.

Aagaard T, Reekie J, Jørgensen M, Roen A, Daugaard G, Specht L, Sengeløv H, Mocroft A, Lundgren J, Helleberg M. Aagaard T, et al. Among authors: mocroft a. Cancer Med. 2020 May;9(9):3033-3042. doi: 10.1002/cam4.2955. Epub 2020 Mar 7. Cancer Med. 2020. PMID: 32144897 Free PMC article.

2

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD. Mocroft A, et al. Lancet. 1998 Nov 28;352(9142):1725-30. doi: 10.1016/s0140-6736(98)03201-2. Lancet. 1998. PMID: 9848347

3

Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group.

Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, Pradier C, dArminio Monforte A, Ledergerber B, Lundgren JD. Mocroft A, et al. AIDS. 1999 May 28;13(8):943-50. doi: 10.1097/00002030-199905280-00010. AIDS. 1999. PMID: 10371175

4

A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.

Mocroft A, Madge S, Johnson AM, Lazzarin A, Clumeck N, Goebel FD, Viard JP, Gatell J, Blaxhult A, Lundgren JD. Mocroft A, et al. J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):369-78. doi: 10.1097/00126334-199912010-00008. J Acquir Immune Defic Syndr. 1999. PMID: 10634199

5

AIDS across Europe, 1994-98: the EuroSIDA study.

Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, Lundgren JD. Mocroft A, et al. Lancet. 2000 Jul 22;356(9226):291-6. doi: 10.1016/s0140-6736(00)02504-6. Lancet. 2000. PMID: 11071184

6

Does European or non-European origin influence health care and prognosis for HIV patients in Europe? The EuroSIDA Study Group.

Blaxhult A, Mocroft A, Phillips A, van Lunzen J, Bentwich Z, Stergiou G, Colebunders R, Benfield TL, Mulcahy F, Lundgren JD. Blaxhult A, et al. Among authors: mocroft a. HIV Med. 1999 Oct;1(1):2-9. doi: 10.1046/j.1468-1293.1999.00002.x. HIV Med. 1999. PMID: 11737323 Free article.

7

A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.

Lundgren JD, Mocroft A, Gatell JM, Ledergerber B, D'Arminio Monforte A, Hermans P, Goebel FD, Blaxhult A, Kirk O, Phillips AN; EuroSIDA Study Group. Lundgren JD, et al. Among authors: mocroft a. J Infect Dis. 2002 Jan 15;185(2):178-87. doi: 10.1086/338267. Epub 2002 Jan 3. J Infect Dis. 2002. PMID: 11807691 Free article.

8

Virological rebound after suppression on highly active antiretroviral therapy.

Mocroft A, Ruiz L, Reiss P, Ledergerber B, Katlama C, Lazzarin A, Goebel FD, Phillips AN, Clotet B, Lundgren JD; EuroSIDA study group. Mocroft A, et al. AIDS. 2003 Aug 15;17(12):1741-51. doi: 10.1097/00002030-200308150-00003. AIDS. 2003. PMID: 12891060

9

Anemia and survival in human immunodeficiency virus.

Lundgren JD, Mocroft A. Lundgren JD, et al. Among authors: mocroft a. Clin Infect Dis. 2003;37 Suppl 4:S297-303. doi: 10.1086/376909. Clin Infect Dis. 2003. PMID: 14581998

10

HIV survival benefit associated with earlier antiviral therapy.

Mocroft A, Phillips AN, Lundgren JD. Mocroft A, et al. Ann Intern Med. 2004 Apr 6;140(7):578-9; author reply 579. doi: 10.7326/0003-4819-140-7-200404060-00024. Ann Intern Med. 2004. PMID: 15068990 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

419 results

Search Page